Industry News
Select develops test to detect Hepatitis A immunity
Select Vaccines (ASX:SLT) announced today it has developed a rapid immunoglobulin G antibody assay to diagnose previous infection with the Hepatitis A virus (HAV). [ + ]
Eureka award winner finds chink in parasites' armour
Molecular parasitologist Dr Sabina Belli finds relief from the stresses of a busy research career in kayaking and white-water rafting. [ + ]
Advice to inventors: if you love it, let it go
Pioneering sleep specialist Dr Murray Johns had some good advice yesterday for medical practitioners wanting to commercialise their medical devices and inventions. [ + ]
Glaciers contribute to climate change
The response of the world’s glaciers to global warming is an important element in understanding climate change, involving sea-level change and changes to the circulation in the North Atlantic. To predict changes, scientists believe it is vital to understand the behaviour of glaciers.
[ + ]Duo fears for DNA privacy
Two Monash law academics are calling for urgent state government action following the disclosure that a private Melbourne company holds the DNA records of millions of Victorians.
[ + ]Chemeq's fall from grace continues
Chemeq’s (ASX:CMQ) prolonged bout of the winter blues have continued even as the first commercial batches of its antimicrobial polymer flow from its new production plant in WA. [ + ]
Pharmaxis healthy, despite clinical trials spend
Pharmaxis (ASX: PXS) has released its preliminary final results, posting a loss of AUD$6 million for the 2003-2004 financial year. [ + ]
Benitec grants license in Ambion settlement
Benitec (ASX: BLT) has settled its patent infringement case against US company Ambion, giving the company a world-wide non-exclusive licence to make and sell DNA-directed RNAi products. [ + ]
Anti-GM protesters disrupt Melbourne’s Biofestival
Anti genetic-engineering protesters smashed full vases containing genetically modified carnations during the afternoon session of the Biofestival 2004 at the Melbourne Exhibition and Convention Centre today. [ + ]
Flies uncovered
Australia will have a much greater capacity to understand its fly biodiversity with a generous endowment from an American benefactor.
[ + ]National neurosciences facility launched
The AUD$4.1 million Integrative Neuroscience Facility of the National Neuroscience Facility was opened today at the NNF headquarters in Melbourne. [ + ]
Quiet ASX debut for BioPharmica
BioPharmica (ASX: BPH) made its debut on the ASX on Friday afternoon, closing slightly lower than its opening price of AUD$0.25 at $0.21. [ + ]
Somnomed propels itself towards the market
Sydney-based company Somnomed is preparing to list on the ASX later this month, with an IPO expected to raise AUD$12 million through the sale of 40 million shares at $0.30 per share. [ + ]
'Just add water' works for BTF
There must be something in the water in Sydney’s North Ryde that encourages biotech. [ + ]
Prana settles clioquinol dispute
Melbourne dementia drug-hunter Prana Biotechnology Ltd (ASX:PBT, NASDAQ:PRAN) has resolved a long-running patent dispute with Greek pharma PN Gerolymatos (PNG) over the composition and uses of Prana’s former lead anti-Alzheimer’s drug, clioquinol, or PBT-1. [ + ]
